REPLICor to Present at  the RSC Virus Molecular Interactions Conference

Laval, Quebec – Sept 16^th , 2007 – Dr Andrew Vaillant, CSO will be presenting the most recent developments in REPLICor’s hepatitis C and influenza programs at the RSC Virus Molecular Interactions Conference in Oxford, UK (Sept. 17-19^th, 2007). The topics of the presentations will be “A novel class of amphipathic DNA polymers inhibits hepatitis C virus infection by blocking viral entry” and “Novel amphipathic DNA polymers REP 9 and REP 9C display activity in vivo against H5N1 and other influenza strains”.